The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Adjuvant Analgesics in Cancer Pain Management
Open accessAbstract
Learning Objectives: After completing this course, the reader will be able to: Identify the indications of adjuvant analgesics in the treatment of cancer pain. Select an appropriate adjuvant analgesic for the treatment of pain in a specific cancer patient. Know the dosing recommendations, side effects, and drug interactions of the most common adjuvant analgesics. Access and take the CME test online and receive 1 hour of AMA PRA category 1 credit at CME.TheOncologist.com Adjuvant analgesics are defined as drugs with a primary indication other than pain that have analgesic properties in some painful conditions. The group includes numerous drugs in diverse classes. Although the widespread use of these drugs as first-line agents in chronic nonmalignant pain syndromes suggests that the term “adjuvant” is a misnomer, they usually are combined with a less-than-satisfactory opioid regimen when administered for cancer pain. Some adjuvant analgesics are useful in several painful conditions and are described as multipurpose adjuvant analgesics (antidepressants, corticosteroids, α2-adrenergic agonists, neuroleptics), whereas others are specific for neuropathic pain (anticonvulsants, local anesthetics, N-methyl-D-aspartate receptor antagonists), bone pain (calcitonin, bisphosphonates, radiopharmaceuticals), musculoskeletal pain (muscle relaxants), or pain from bowel obstruction (octreotide, anticholinergics). This article reviews the evidence supporting the use of each class of adjuvant analgesic for the treatment of pain in cancer patients and provides a comprehensive outline of dosing recommendations, side effects, and drug interactions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Adult Cancer Pain, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Swarm, R. A., Paice, J. A., Anghelescu, D. L., Are, M., Bruce, J. Y., Buga, S., Chwistek, M., Cleeland, C., Craig, D., Gafford, E., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0038 · Cited by 621
Perineural invasion and associated pain in pancreatic cancer
Bapat, A. A., Hostetter, G., Von Hoff, D. D., & Han, H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3131 · Cited by 501
Swarm, R., Abernethy, A. P., Anghelescu, D. L., Benedetti, C., Blinderman, C. D., Boston, B., Cleeland, C., Coyle, N., deLeon-Casasola, O. A., Eilers, J. G., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0076 · Cited by 319
Vila, H., Smith, R. A., Augustyniak, M. J., Nagi, P. A., Soto, R. G., Ross, T. W., Cantor, A. B., Strickland, J. M., & Miguel, R. V. (2005) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000155970.45321.a8 · Cited by 267
Metadata
- Authors
- Lussier, D., Huskey, A. G., & Portenoy, R. K.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-09-01
- Volume
- 9
- Issue
- 5
- Pages
- 571-591
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- OpenAlex
- W2023338676
- Cited by
- 249
- References
- 1
- FWCI
- 10.55
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adjuvant Analgesics in Cancer Pain Management. https://app.cochat.ai/papers/10.1634/theoncologist.9-5-571
- The paper
- Lussier, D., Huskey, A. G., & Portenoy, R. K. (2004). Adjuvant Analgesics in Cancer Pain Management. The Oncologist. https://doi.org/10.1634/theoncologist.9-5-571
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.